Description
CYRAMZA
First action · last action
2014-06-12 · 2016-06-28
Transactions
2
First transaction's obligation
$59,976
Base + all options value (sum of deltas)
$52,479
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-06-12+$59,976= $59,976
- Mod P000012016-06-28-$7,497= $52,479
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-06-12 | +$59,976 | $59,976 | CYRAMZA |
| Mod P00001· CLOSE OUT | 2016-06-28 | −$7,497 | $52,479 | CYRAMZA |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI U7XLCG7L2LC5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24226P0887 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $19,215 | FY2026 |
| 36C24226P0878 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $15,609 | FY2026 |
| 36C24526P0520 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $19,215 | FY2026 |
| 36C24226P0738 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $19,215 | FY2026 |
| 36C24526P0488 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $19,215 | FY2026 |
| 36C24226P0662 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $19,215 | FY2026 |
Other recipients under 6515 from 437-FARGO VA MEDICAL CENTER (00437) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26323N0089 | ROCHE DIAGNOSTICS CORPORATION | 437-FARGO VA MEDICAL CENTER (00437) | $588,985 | FY2023 |
| 36C26318P0461 | EVOQUA WATER TECHNOLOGIES LLC | 437-FARGO VA MEDICAL CENTER (00437) | $14,620 | FY2018 |
| 36C26318P0368 | ALLIANT ENTERPRISES, LLC | 437-FARGO VA MEDICAL CENTER (00437) | $52,660 | FY2018 |
| 36C26318P0441 | ANALOGIC CORP | 437-FARGO VA MEDICAL CENTER (00437) | $7,315 | FY2018 |
| 36C26318F0397 | CRYSTAL CLEAR TECHNOLOGIES INC | 437-FARGO VA MEDICAL CENTER (00437) | $5,758 | FY2018 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26314P1004_3600_-NONE-_-NONE- · retrieved 2026-09-26.